Fabio
6.0 KiB
6.0 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Prescription drug pricing. | Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law defines a "covered entity" to include a federally qualified health center and entities receiving specified grants and federal funding. | us/states/ca | California Legislature | 20232024 | SB 786 | California SB 786 (20232024) |
|
|
enacted |
|
7 | 19 | 5 | 2023-02-17 | 2023-10-07 | openstates | ocd-bill/d4d889e8-eed9-4204-a5fd-21e201fe8d86 | http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240SB786 | f3466e95d536363a9cef16ed63f4520bca9b81681ab7893e5a61f1c9d650a88c | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
California SB 786 (20232024) — Prescription drug pricing.
Existing federal law requires the United States Secretary of Health and Human Services to enter into an agreement with each manufacturer of covered outpatient drugs to ensure the amount a covered entity is required to pay for those drugs does not exceed the average manufacturer price of the drug under the federal Medicaid program. Existing state law requires a covered entity to dispense only drugs subject to these federal pricing requirements to Medi-Cal beneficiaries. Existing law defines a "covered entity" to include a federally qualified health center and entities receiving specified grants and federal funding.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- 02/17/23 - Introduced (filed) — source
- 03/27/23 - Amended Senate (committee substitute) — source
- 04/24/23 - Amended Senate (committee substitute) — source
- 06/15/23 - Amended Assembly (committee substitute) — source
- 10/07/23 - Chaptered (committee substitute) — source
- SB786 (committee substitute) — source
- 09/08/23 - Enrolled (enrolled) — source
Votes
- Do pass as amended — 9–0 (pass) · upper
- SB 786 Portantino Senate Third Reading By Zbur — 76–0 (pass) · lower
- Do pass. — 15–0 (pass) · lower
- 3rd Reading — 35–0 (pass) · upper
- Unfinished Business SB786 Portantino Concurrence — 40–0 (pass) · upper
Sponsors
- Portantino — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2023-02-17 Introduced. Read first time. To Com. on RLS. for assignment. To print.
introduction, reading-1 - 2023-02-21 From printer. May be acted upon on or after March 20.
- 2023-03-01 Referred to Com. on HEALTH.
referral-committee - 2023-03-27 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
amendment-passage, committee-passage, reading-1, reading-2, referral-committee - 2023-04-03 Set for hearing April 19.
- 2023-04-20 From committee: Do pass as amended. (Ayes 9. Noes 0. Page 832.) (April 19).
amendment-passage, committee-passage, committee-passage-favorable - 2023-04-24 Read second time and amended. Ordered to third reading.
amendment-passage, reading-1, reading-2 - 2023-05-22 Read third time. Passed. (Ayes 35. Noes 0. Page 1205.) Ordered to the Assembly.
passage, reading-1, reading-3 - 2023-05-23 In Assembly. Read first time. Held at Desk.
reading-1 - 2023-05-26 Referred to Com. on HEALTH.
referral-committee - 2023-06-15 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
amendment-passage, committee-passage, reading-1, reading-2, referral-committee - 2023-07-12 From committee: Do pass. (Ayes 15. Noes 0.) (July 11).
committee-passage, committee-passage-favorable - 2023-07-13 Read second time. Ordered to third reading.
reading-1, reading-2 - 2023-08-24 Read third time. Passed. (Ayes 76. Noes 0. Page 2794.) Ordered to the Senate.
passage, reading-1, reading-3 - 2023-08-24 In Senate. Concurrence in Assembly amendments pending.
- 2023-09-06 Assembly amendments concurred in. (Ayes 40. Noes 0. Page 2419.) Ordered to engrossing and enrolling.
amendment-passage, committee-passage-favorable - 2023-09-11 Enrolled and presented to the Governor at 3 p.m.
- 2023-10-07 Approved by the Governor.
executive-signature - 2023-10-07 Chaptered by Secretary of State. Chapter 414, Statutes of 2023.
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d4d889e8-eed9-4204-a5fd-21e201fe8d86. Confidence: reported (aggregated from official California legislature records).